New method of therapeutic use of compound Bauhinia sp. and Psidium SP applied in influenza

摘要

New method of therapeutic use of compound Bauhinia sp. and Psidium SP applied in influenza. Influenza is a major cause of respiratory disease in humans and animals. It is an important cause of morbidity, disability and mortality, especially during and after epidemics and pandemics.Triggers severe complications such as pneumonia, bronchitis, myocarditis, sinusitis, otitis media, dementia, epilepsy, cerebrovascular disease, encephalitis, meningitis, subarachnoid hemorrhage, psychosis, schizophrenia, Parkinson's disease, rhabdomyolysis, pulmonary embolism etc.The current treatment with antivirals gives poor results, with high toxicity, with disabling or fatal side effects, in addition to select resistant variants. The vaccine available is ineffective, expensive and with serious side effects, disabling or fatal. However, influenza is immune disorder.There is an increase of both local and systemic cytokine, reinforced by secondary infections.This patent relates to a new method of therapeutic use for the compound Bauhinia sp. and Psidium SP used for influenza in which highlights the application of this drug in combination with antibiotic therapy, where the medicine is presented as an immunomodulator, viricida, antibiu00f3tic The, analgesic, anti convulsant, antitussu00edgeno,For the simultaneous treatment of the cause and prevention of serious complications and fatal, no toxicity, showing greater simplicity, efficiency and effectiveness of the technique practical immune restoration in the treatment and prevention of influenza, with ample human and veterinary use.